PPARGC1A and myeloid sarcoma: This review summarizes the current state of knowledge about certain endogenous molecular pathways with the potential ability to influence the pathogenesis and/or course of MS, with special emphasis on peroxisome proliferator-activated receptors (PPARs), PPARγ coactivator-1alpha (PGC-1α), and the kynurenines.